TrialCNS drugs2025

Adjunctive PCSK9 Inhibitor Evolocumab in the Prevention of Early Neurological Deterioration in Non-cardiogenic Acute Ischemic Stroke: A Multicenter, Prospective, Randomized, Open-Label, Clinical Trial.

Wen Tian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.